We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4.92B
AUM Growth
+$1.62B
Cap. Flow
+$1.41B
Cap. Flow %
28.67%
Top 10 Hldgs %
36.75%
Holding
1,419
New
468
Increased
176
Reduced
163
Closed
410

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$208M
2
AMZN icon
Amazon
AMZN
+$165M
3
AMD icon
Advanced Micro Devices
AMD
+$86.9M
4
XYZ
Block Inc
XYZ
+$33.2M
5
ROKU icon
Roku
ROKU
+$27M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$10.3M
2
MRNA icon
Moderna
MRNA
+$9.79M
3
JD icon
JD.com
JD
+$6.14M
4
AZN icon
AstraZeneca
AZN
+$5.27M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.32M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.5%
2 Technology 4.33%
3 Communication Services 2.49%
4 Healthcare 1.87%
5 Financials 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPTU
376
PUT
Optimum Communications Inc
OPTU
$290M
$1.62M 0.03%
+100,000
New +$1.7M
ZNGA
377
CALL
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$1.6M 0.03%
250,000
-42,500
-15% -$293K
BEAM icon
378
CALL
Beam Therapeutics
BEAM
$2.73B
$1.59M 0.03%
+20,000
New +$1.71M
BEAM icon
379
PUT
Beam Therapeutics
BEAM
$2.73B
$1.59M 0.03%
+20,000
New +$1.71M
KRYS icon
380
PUT
Krystal Biotech
KRYS
$10.8B
$1.59M 0.03%
22,700
+13,200
+139% +$768K
NKE icon
381
Nike
NKE
$62.7B
$1.58M 0.03%
9,500
+4,000
+73% +$660K
AMT icon
382
CALL
American Tower
AMT
$81.3B
$1.58M 0.03%
5,400
-21,600
-80% -$5.9M
TGTX icon
383
CALL
TG Therapeutics
TGTX
$8.19B
$1.58M 0.03%
83,100
+20,700
+33% +$537K
UNFI icon
384
CALL
United Natural Foods
UNFI
$3.01B
$1.57M 0.03%
32,000
-18,000
-36% -$870K
BIIB icon
385
Biogen
BIIB
$30.7B
$1.56M 0.03%
6,500
-5,000
-43% -$1.29M
GE icon
386
CALL
GE Aerospace
GE
$368B
$1.54M 0.03%
+26,163
New +$1.64M
CIEN icon
387
PUT
Ciena
CIEN
$52.7B
$1.54M 0.03%
20,000
– –
DD icon
388
CALL
DuPont de Nemours
DD
$18.7B
$1.53M 0.03%
15,137
-79,666
-84% -$7.58M
MSOS icon
389
AdvisorShares Pure US Cannabis ETF
MSOS
$854M
$1.53M 0.03%
+60,000
New +$1.66M
EHTH icon
390
CALL
eHealth
EHTH
$43.8M
$1.53M 0.03%
60,000
+10,000
+20% +$332K
PAR icon
391
PUT
PAR Technology
PAR
$695M
$1.52M 0.03%
28,900
+9,000
+45% +$542K
NBIS
392
PUT
Nebius Group N.V.
NBIS
$47.8B
$1.51M 0.03%
25,000
– –
BHP icon
393
CALL
BHP
BHP
$218B
$1.51M 0.03%
28,025
– –
NTR icon
394
CALL
Nutrien
NTR
$33.9B
$1.5M 0.03%
+20,000
New +$1.4M
SNY icon
395
Sanofi
SNY
$103B
$1.5M 0.03%
30,000
+24,851
+483% +$1.23M
NVCR icon
396
PUT
NovoCure
NVCR
$1.77B
$1.5M 0.03%
20,000
+10,000
+100% +$1M
LRN icon
397
PUT
Stride
LRN
$3.53B
$1.5M 0.03%
+45,000
New +$1.55M
PLNT icon
398
CALL
Planet Fitness
PLNT
$4.43B
$1.5M 0.03%
16,500
– –
YETI icon
399
PUT
Yeti Holdings
YETI
$3.76B
$1.49M 0.03%
18,000
– –
APO icon
400
PUT
Apollo Global Management
APO
$69.3B
$1.49M 0.03%
20,500
– –
14 15
16
17 18

Similar funds

EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

SG3 Management's Q4 2021 Portfolio in Review

As of Q4 2021, SG3 Management held 1,419 positions worth $4.92B, up 49% from $3.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

SG3 Management deployed $1.41B of net new capital in Q4 2021, opening 468 new positions and adding to 176 existing holdings. Its largest new stake was Tesla: 619,500 shares worth $218M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.5% of assets, up from 0.74% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Moderna, an estimated $9.79M trimmed.

  • SG3 Management's largest Q4 2021 buy was Tesla: 619,500 shares worth $218M.
  • SG3 Management added most to Amazon in Q4 2021, an estimated $165M increase.
  • SG3 Management's biggest Q4 2021 reduction was Moderna, cutting an estimated $9.79M.
  • SG3 Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $10.3M.
  • SG3 Management's ten largest holdings make up 37% of its $4.92B portfolio in Q4 2021.
  • SG3 Management opened 468 new positions and closed 410 in Q4 2021.
  • SG3 Management's portfolio value rose 49% quarter-over-quarter to $4.92B.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.